Bipartite structure and functional independence of adenovirus type 5 packaging elements

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3375-3384

  Schmid, Susanne I ^a   Hearing, Patrick ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DNA PACKAGING; GENE LOCATION; GENE TARGETING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; VIRUS MORPHOLOGY; VIRUS TRANSCRIPTION;

EID: 0030894765     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3375-3384.1997     Document Type: Article

References (33)

1. Bjornsti, M. A., B. E. Reilly, and D. L. Anderson. 1983. Morphogenesis of bacteriophage φ29 of Bacillus subtilis: oriented and quantized in vitro packaging of DNA protein gp3. J. Virol. 45:383-396.
2. Bolwig, G. M., J. T. Bruder, and P. Hearing. 1992. Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A. Nucleic Acids Res. 20:6555-6564.
3. Brough, D. E., A. Lizonova, C. Hsu, V. A. Kulesa, and I. Kovesdi. 1996. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J. Virol. 70:6497-6501.
4. Bruder, J. T., and P. Hearing. 1989. Nuclear factor EF-1A binds to the adenovirus E1A core enhancer element and to other transcriptional control regions. Mol. Cell. Biol. 9:5143-5153.
5. Daniell, E. 1976. Genome structure of incomplete particles of adenovirus. J. Virol. 19:685-708.
6. D'Halluin, J.-C., M. Milleville, P. A. Boulanger, and G. R. Martin. 1978. Temperature-sensitive mutant of adenovirus type 2 blocked in virion assembly: accumulation of light intermediate particles. J. Virol. 26:344-356.
7. D'Halluin, J.-C., M. Milleville, G. R. Martin, and P. Boulanger. 1980. Morphogenesis of human adenovirus type 2 studied with fiber- and penton base-defective temperature-sensitive mutants. J. Virol. 33:88-99.
8. D'Halluin, J. C., G. R. Martin, G. Torpier, and P. A. Boulanger. 1978. Adenovirus type 2 assembly analyzed by reversible cross-linking of labile intermediates. J. Virol. 26:357-363.
9. Earnshaw, W. C., and S. R. Casjens. 1980. DNA packaging by the double-stranded DNA bacteriophages. Cell 21:319-331.
10. Edvardsson, B., E. Everitt, E. Joernvall, L. Prage, and L. Philipson. 1976. Intermediates in adenovirus assembly. J. Virol. 19:533-547.
11. Edvardsson, B., S. Ustacelebi, J. Williams, and L. Philipson. 1978. Assembly intermediates among adenovirus type 5 temperature-sensitive mutants. J. Virol. 25:641-651.
12. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196-6200.
13. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
14. Fredman, J. N., S. C. Pettit, M. S. Horwitz, and J. A. Engler. 1991. Linker insertion mutations in the adenovirus preterminal protein that affect DNA replication activity in vivo and in vitro. J. Virol. 65:4591-4597.
15. Freimuth, P. L., and H. S. Ginsberg. 1986. Codon insertion mutants of the adenovirus terminal protein. Proc. Natl. Acad. Sci. USA 83:7816-7820.
16. Graeble, M., and P. Hearing. 1990. Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant. J. Virol. 64:2047-2056.
17. Graeble, M., and P. Hearing. 1992. cis and trans requirements for the selective packaging of adenovirus type 5 DNA. J. Virol. 66:723-731.
18. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairu. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
19. Hammarskjoeld, M.-L., and G. Winberg. 1980. Encapsidation of adenovirus 16 DNA is directed by a small DNA sequence at the left end of the genome. Cell 20:787-795.
20. Hearing, P., R. J. Samulski, W. L. Wishart, and T. Shenk. 1987. Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J. Virol. 61:2555-2558.
21. Hearing, P., and T. Shenk. 1983. The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell 33:695-703.
22. Hearing, P., and T. Shenk. 1986. The adenovirus type 5 E1A enhancer contains two functionally distinct domains: one is specific for E1A and the other modulates all early units in cis. Cell 45:229-236.
23. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
24. Jones, N., and T. Shenk. 1979. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17: 683-689.
25. Kosturko, L. D., S. V. Sharnick, and C. Tibbetts. 1982. Polar encapsidation of adenovirus DNA: cloning and DNA sequence of the left end of adenovirus type 3. J. Virol. 43:1132-1137.
26. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
27. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
28. Pettit, S. C., M. S. Horwitz, and J. A. Engler. 1989. Mutations of the precursor to the preterminal protein of adenovirus serotypes 2 and 5. J. Virol. 63:5244-5250.
29. Robbinson, C. C., and C. Tibbetts. 1984. Polar encapsidation of adenovirus DNA: evolutionary variants reveal dispensable sequences near the left ends of Ad3 genomes. Virology 137:276-286.
30. Stow, N. D. 1981. Cloning a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis. J. Virol. 37:171-180.
31. Tibbetts, C. 1977. Viral DNA sequences from incomplete particles of human adenovirus type 7. Cell 12:243-249.
32. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limit E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
33. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2A in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:362-369.